Abstract
Helicobacter pylori (H. pylori) infects the gastric mucosa and causes pathological gastritis. H. pylori infection often persists for life and chronic inflammation of the gastric mucosa leads to a wide variety of upper gastrointestinal tract diseases, such as atrophic gastritis, gastric/duodenal ulcer, gastric cancer, gastric MALT lymphoma, and hyperplastic gastric polyps (1).
Irrespective of their histology, most gastric cancers arise from mucosa infected by H. pylori, and these tumors very rarely arise from gastric mucosa without inflammation. Therefore, H. pylori is considered to be the factor most strongly related to the development of gastric cancer. In Japan, 80% or more of H. pylori-infected persons will develop atrophic gastritis (2) . Studies have shown that the presence of gastric mucosal atrophy and intestinal metaplasia increase the risk of gastric cancer (3) (4) . After this, studies using Mongolian gerbils with H. pylori infection (5, 6 ) and a prospective study (7) (Fig. 1). When considering the suppressive effect of H. pylori eradication, in F i g u r e 1 . Di f f e r e n c e i n t h e e f f e c t o f e r a d i c a t i o n o f H. p y l o r i t o p r e v e n t g a s t r i c c a n c e r b e t we e n t wo s t u d i e s . 
